GOSY yields 2000000.00% · JNJ yields 2.13%● Live data
📍 GOSY pulled ahead of the other in Year 1
Combined, GOSY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GOSY + JNJ for your $10,000?
GeckoSystems International Corporation engages in the development and supply of mobile robot solutions for safety, security, and service to the consumer, business, and government markets. It offers mobile service robots (MSRs) that automatically self-navigate homes or workplace. The company's products comprise GeckoNav, an automatic navigation control system based on fuzzy hybrid architecture; GeckoSuper that acts as the central hub through which GeckoSavants communicate with each other; GeckoScheduler that enables mobile robots to timely and repetitively remind the care receiver of various events; GeckoChat, a conversational artificial intelligence system that allows the user to verbally interact with those GSI systems, which have GeckoChat bilateral communication capability; and GeckoTrak, which merges and interprets data from sensor systems to achieve sensor fusion to automatically follow a designated person anywhere in the home. Its products also include GeckoSPIO, a robot controller circuit board that contains passive and active components; GeckoImager, which allows the system to process approximately 2,000 times more raw data than the CompoundedSensorArray system; GeckoOrient, which merges sensor data from odometry for enhanced orientation accuracy while errand running, patrolling, or following a designated person; GeckoSteer, a solution to address issues unique to the collision proof wheelchair; and GeckoMotorController that uses feedback from optical encoders to control wheel velocity. In addition, the company provides GeckoZap, a test, calibrate, and debug software suite; and CareBot MSR technology. GeckoSystems Intl. Corp. was founded in 1997 and is based in Conyers, Georgia.
Full GOSY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.